Keyphrases
Lynch Syndrome
64%
Colorectal Cancer
54%
Inflammatory Bowel Disease
52%
Colonoscopy
50%
Adenoma
42%
Polyps
39%
Liver Transplant Recipients
37%
Colon Cancer
36%
Pathogenic Variants
33%
Crohn's Disease
33%
Surveillance Colonoscopy
33%
Healthy Controls
30%
Telomere
29%
Primary Sclerosing Cholangitis
28%
Placenta
28%
Poisoning
28%
Mismatch Repair Genes
26%
Colonoscopy Surveillance
25%
Telomere Length
24%
Advanced Adenoma
24%
Telomere Capture
24%
Metabolic Syndrome
23%
Risk Factors
23%
Cryptogenic Cirrhosis
22%
Telomere Shortening
21%
MSH2
20%
High Risk
19%
Telomere Dysfunction
19%
Non-alcoholic Fatty Liver Disease (NAFLD)
19%
Metachronous
19%
BRCA1, BRCA2
18%
Novel Biomarkers
18%
Advanced Neoplasia
18%
Hyperammonemic Encephalopathy
18%
Asynchronous Replication
18%
Pancreatic Ductal Adenocarcinoma
18%
Young Patients
18%
Potential Treatments
18%
Bifunctional Compounds
18%
Colitis
18%
Blister
18%
Nerve
18%
Chemical Agents
18%
Anticholinesterase
18%
Screening Colonoscopy
18%
Peripheral Blood Lymphocytes
17%
Polyposis
17%
Human Telomerase Reverse Transcriptase (hTERT)
16%
Israeli
15%
Germ Cells
15%
Medicine and Dentistry
Colonoscopy
100%
Adenoma
61%
Polyp
58%
Colorectal Cancer
51%
Malignant Neoplasm
45%
Hereditary Nonpolyposis Colorectal Cancer
43%
Neoplasm
39%
Colon Cancer
36%
Biological Marker
29%
DNA Mismatch Repair
28%
Liver Graft
28%
Inflammatory Bowel Disease
24%
Gene Repair
22%
Polypectomy
21%
Cancer Syndrome
21%
Tubular Adenoma
21%
Disease
19%
Syndecan 1
18%
BRCA1
18%
Colitis
18%
Pancreas Adenocarcinoma
17%
Juvenile Polyposis Syndrome
15%
Ulcerative Colitis
14%
Crohn's Disease
14%
Genetic Screening
14%
Colon Polyp
13%
BRCA2
13%
Surgery
13%
Prevalence
12%
Diagnosis
12%
Metabolic Syndrome
12%
Colorectal Adenoma
12%
Patient with Inflammatory Bowel Disease
12%
Diabetes Mellitus
11%
Pancreas Cancer
11%
Polyposis
11%
Early Cancer Diagnosis
10%
Telomere
10%
Diverticulum
10%
Case-Control Study
10%
Penetrance
10%
Cancer
10%
Odds Ratio
9%
Open-Label Trial
9%
Sodium Bicarbonate
9%
Telomere Shortening
9%
Multiple Endocrine Neoplasia Type I
9%
Patient with Ulcerative Colitis
9%
Primary Sclerosing Cholangitis
9%
Placenta
9%